Related Experiment Video

Updated: Sep 20, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.2K

Small Molecules Targeting Non-Coding RNAs Regulating Ferroptosis: New Opportunities in Precision Cancer Therapy

Junjing Zhang1, Yan Wang2, Joshua S Fleishman3

  • 1Department of Hepato-Biliary Surgery, Department of Surgery, Hohhot First Hospital, Hohhot, P.R. China.

Antioxidants & Redox Signaling
|May 23, 2025
PubMed

Insights

Ferroptosis, a regulated cell death (RCD) form, shows promise in cancer therapy. Small-molecule compounds targeting non-coding RNAs (ncRNAs) offer a new precision strategy for cancer treatment by modulating ferroptosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Ferroptosis, a distinct form of regulated cell death (RCD), is a promising strategy for inhibiting tumor malignancy.
  • Non-coding RNAs (ncRNAs) are crucial in cancer initiation, metastasis, and drug resistance, and regulate ferroptosis susceptibility via epigenetic modifications.

Purpose of the Study:

  • To elucidate molecular mechanisms of ncRNA-mediated ferroptosis regulation in cancer.
  • To investigate small-molecule compounds (SMCs) as therapeutic agents for modulating ncRNA-ferroptosis axis in cancer treatment.

Main Methods:

  • Literature review of current research on ncRNAs, ferroptosis, and SMCs in cancer.
  • Analysis of molecular pathways linking ncRNAs, epigenetic modifications, and ferroptosis.
  • Evaluation of therapeutic potential of SMCs targeting ncRNAs for cancer therapy.

Main Results:

  • ncRNAs play a significant role in regulating cancer cell ferroptosis susceptibility.
  • SMCs can effectively target ncRNAs to modulate ferroptosis.
  • Targeting the ncRNA-ferroptosis axis with SMCs presents a novel precision cancer therapy strategy.

Conclusions:

  • ncRNA-mediated ferroptosis is a key mechanism in cancer progression and treatment response.
  • SMCs offer a viable approach for pharmacologically targeting the ncRNA-ferroptosis axis.
  • This strategy holds significant potential for advancing precision cancer therapy.
Keywords:
CancerFerroptosisNon-coding RNAsSmall molecules

More Related Videos

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.3K
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

5.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K